167 results
Biosimilars role in IBD treatment
Have you received a notification from your insurance carrier that coverage of your specialty medication is changing? If so, you aren’t the only one. Many of my patients who are on biologics have been informed by their insurer that they are now required to switch to a biosimilar. I know this can soun...
Read more... Treating IBD by rebalancing the gut microbiome
Everyone has a mix of microbes in their gut, some of which are beneficial and others that can wreak havoc—especially in people with Crohn’s disease and ulcerative colitis. Thanks, in part, to funding through IBD Ventures (our venture philanthropy program), researchers at Vedanta Biosciences are...
Read more... In memory of Donald Kortz, Crohn’s & Colitis Foundation National Trustee
The Crohn’s & Colitis Foundation staff and volunteers were saddened to learn of the passing of Donald (Don) Kortz, a member of our National Board of Trustees, last week. Don and his family first became involved with the Foundation after their daughter Zoey was diagnosed with IBD. “...
Read more... Anti-TNF therapy could lower colorectal cancer risk for IBD patients
Receiving a colorectal cancer diagnosis on top of one for IBD may be the last thing a patient wants to hear. A patient’s risk of developing colorectal cancer depends on certain factors, including if they have ulcerative colitis or Crohn’s disease affecting the colon, they have had IBD for eight year...
Read more... Updates on COVID-19 vaccine research in patients with IBD
Over 141 million people in the United States are fully vaccinated against COVID-19 - 49% of the total population in our country. Although we don’t precisely know vaccination rates among patients with IBD, we are pleased to see many patients getting vaccinated and encouraging their friends and family...
Read more... What it's like to be LGBTQ+ with IBD
Every June during Pride, I'm reminded of how fortunate that I am. I can live in a country where I'm free to be myself and share my life openly with my husband of 20 years. I know that we can thrive because our life consists of lots of love and support. Support from the many facets of our family; And...
Read more... What it’s like to live with IBD around the world
More than 10 million people worldwide live with Crohn’s disease or ulcerative colitis. Living with these diseases is very individual and no patient experiences the same symptoms or manifestations of disease. But what bonds everyone — regardless of whether they live in the United States, India, Austr...
Read more... Opioid use as a driver of cost of IBD care
Approximately 50-70% of IBD patients report experiencing abdominal pain at some point during their disease journey. But when that pain becomes chronic, treating it can become difficult and costly. In fact, the results from the Foundation’s Cost of IBD Care study from 2019 found that prescription opi...
Read more... Are IBD patients protected by the COVID-19 vaccines?
The New York Times recently published an article claiming that the COVID-19 vaccines won’t protect individuals with weakened immune systems. Within that article, they stated that, according to the CLARITY IBD Study of patients in the United Kingdom, only 34% of people on infliximab (Remicade) were p...
Read more... PIANO Study offers hope and comfort to prospective and current IBD moms
When you live with inflammatory bowel disease (IBD), the question of how your Crohn’s or ulcerative colitis is going to impact conception, pregnancy, and motherhood is top of mind for many women since most of us receive our diagnosis during or before our childbearing years. As I write this, I’...
Read more...